BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38396990)

  • 1. Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation.
    Zakynthinos GE; Tsolaki V; Oikonomou E; Pantelidis P; Gialamas I; Kalogeras K; Zakynthinos E; Vavuranakis M; Siasos G
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Predictive Value of Endothelial Dysfunction for Arrhythmia Recurrence Following Pulmonary Vein Isolation.
    Matsuzawa Y; Suleiman M; Guddeti RR; Kwon TG; Monahan KH; Lerman LO; Friedman PA; Lerman A
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27613771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial function and atrial fibrillation: A missing piece of the puzzle?
    Black N; Mohammad F; Saraf K; Morris G
    J Cardiovasc Electrophysiol; 2022 Jan; 33(1):109-116. PubMed ID: 34674346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation of persistent atrial fibrillation : Beneficial effect of a short-term adjunctive amiodarone therapy on the long-term outcome.
    Kettering K; Gramley F
    Herzschrittmacherther Elektrophysiol; 2018 Mar; 29(1):133-140. PubMed ID: 28447159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.
    Okawa K; Miyoshi T; Tsukuda S; Hara S; Matsuo N; Nishibe N; Sogo M; Okada T; Nosaka K; Sakane K; Doi M; Morita H; Ito H
    Int J Cardiol; 2017 Oct; 244():180-185. PubMed ID: 28668398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
    Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
    Nery PB; Wells GA; Verma A; Joza J; Nair GM; Veenhuyzen G; Andrade J; Nault I; Wong JA; Sikkel M; Essebag V; Macle L; Sapp J; Roux JF; Skanes A; Angaran P; Novak P; Redfearn D; Golian M; Redpath CJ; Sturmer M; Birnie D
    Am Heart J; 2022 Dec; 254():133-140. PubMed ID: 36030965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of persistent atrial fibrillation: anatomically based circumferential pulmonary vein ablation in combination with a potential-guided segmental approach to achieve complete pulmonary vein isolation.
    Kettering K; Weig HJ; Busch M; Schneider KM; Eick C; Weretka S; Laszlo R; Gawaz M; Schreieck J
    J Interv Card Electrophysiol; 2011 Jan; 30(1):63-72. PubMed ID: 21253841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review.
    Alrumayh A; Alobaida M
    Ann Med; 2021 Dec; 53(1):551-557. PubMed ID: 33783271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary catheter ablation of atrial fibrillation].
    Ernst S; Henningsen C; Reisewitz G; Kuck KH
    Herz; 2002 Jun; 27(4):370-7. PubMed ID: 12187867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for atrial fibrillation recurrence after catheter ablation].
    Wu C; Xu Q; Shi R; Zhang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1196-1202. PubMed ID: 31857516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association.
    Arbelo E; Brugada J; Hindricks G; Maggioni AP; Tavazzi L; Vardas P; Laroche C; Anselme F; Inama G; Jais P; Kalarus Z; Kautzner J; Lewalter T; Mairesse GH; Perez-Villacastin J; Riahi S; Taborsky M; Theodorakis G; Trines SA;
    Eur Heart J; 2014 Jun; 35(22):1466-78. PubMed ID: 24487524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE; Bahnson TD; Monahan KH; Johnson G; Rostami H; Silverstein AP; Al-Khalidi HR; Rosenberg Y; Mark DB; Lee KL; Packer DL;
    J Am Coll Cardiol; 2020 Jun; 75(25):3105-3118. PubMed ID: 32586583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal Atrial Fibrillation Ablation Using a Novel Variable-Loop Biphasic Pulsed Field Ablation Catheter Integrated With a 3-Dimensional Mapping System: 1-Year Outcomes of the Multicenter inspIRE Study.
    Duytschaever M; De Potter T; Grimaldi M; Anic A; Vijgen J; Neuzil P; Van Herendael H; Verma A; Skanes A; Scherr D; Pürerfellner H; Rackauskas G; Jaïs P; Reddy VY;
    Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011780. PubMed ID: 36735937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
    Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
    Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of paroxysmal atrial fibrillation: circumferential pulmonary vein ablation: success rates with and without exclusion of areas adjacent to the esophagus.
    Kettering K; Yim DH; Benz A; Gramley F
    Clin Res Cardiol; 2017 Sep; 106(9):743-751. PubMed ID: 28492985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation ablation.
    Pappone C; Santinelli V
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):560-9. PubMed ID: 22541284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST-END study.
    Lo M; Nair D; Mansour M; Calkins H; Reddy VY; Colley BJ; Tanaka-Esposito C; Sundaram S; DeLurgio DB; Sanders P; Khatib S; Bernard M; Olson N; Gibson D; Miller A; Li J; Natale A
    J Cardiovasc Electrophysiol; 2023 Feb; 34(2):279-290. PubMed ID: 36352771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional therapy of atrial fibrillation: possibilities and limitations].
    Willems S; Drewitz I; Steven D; Hoffmann BA; Meinertz T; Rostock T
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S48-54. PubMed ID: 20221979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.